Pediatric inflammatory bowel disease: specificity of very early onset

References

• Cutler DJ, Zwick ME, Okou DT. Dissecting allele architecture of early onset IBD using high-density genotyping. Plos One. 2015 June 22;10:e0128074. doi:10.1371/journal.pone.0128074.
   Web of Science ®Google Scholar
• Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–1794.
   PubMed Web of Science ®Google Scholar
• Khor B, Gardet A, Xavier R. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307–317.
   PubMed Web of Science ®Google Scholar
• Levine A, Anne Griffiths A, James Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314–1321.
   PubMed Web of Science ®Google Scholar
• Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal world congress of gastroenterology. Can J Gastroenterol. 2005;19:5–36.
   PubMed Web of Science ®Google Scholar
• Levine A, Kugathasan S, Annese V, et al. Pediatric onset Crohn’s colitis is characterized by genotype-dependent age-related susceptibility. Inflamm Bowel Dis. 2007;13:1509–1515.
   PubMed Web of Science ®Google Scholar
• Meinzer U, Ideström M, Alberti C, et al. Ileal involvement is age dependent in pediatric Crohn’s disease. Inflamm Bowel Dis. 2005;11:639–644.
   PubMed Web of Science ®Google Scholar
• Markowitz J, Kugathasan S, Dubinsky M, et al. Age of diagnosis influences serologic responses in children with Crohn’s disease: a possible clue to etiology? Inflamm Bowel Dis. 2009;15:714–719.
   PubMed Web of Science ®Google Scholar
• Mamula P, Telega GW, Markowitz JE, et al. Inflammatory bowel disease in children 5 years of age and younger. Am J Gastroenterol. 2002;97:2005–2010.
   PubMed Web of Science ®Google Scholar
• Cannioto Z, Berti I, Martelossi S, et al. IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Eur J Pediatr. 2009;168:149–155.
   PubMed Web of Science ®Google Scholar
• Ruemmele FM, El Khoury MG, Talbotec C, et al. Characteristics of inflammatory bowel disease with onset during the first year of life. J Pediatr Gastroenterol Nutr. 2006;43:603–609.
   PubMed Web of Science ®Google Scholar
• Uhlig HH. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease. Gut. 2013;62:1795–1805.
   PubMed Web of Science ®Google Scholar
• Uhlig HH, Schwerd T, Koletzko S, et al.; for the COLORS in IBD Study Group and NEOPICS. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147:990–1007.
   PubMed Web of Science ®Google Scholar
• Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–124.
   PubMed Web of Science ®Google Scholar
• Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol. 2012;46:581–589.
   PubMed Web of Science ®Google Scholar
• Glocker E-O, Kotlarz D, Klein C, et al. IL-10 and IL-10 receptor defects in humans. Ann N Y Acad Sci. 2011;1246:102–107.
   PubMed Web of Science ®Google Scholar
• Baldassano RN, Piccoli DA. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am. 1999;28:445–458.
   PubMed Web of Science ®Google Scholar
• Hyams JS. Crohn’s disease in children. Pediatr Clin North Am. 1996;43:255–277.
   PubMed Web of Science ®Google Scholar
• Hyams JS, Davis P, Grancher K, et al. Clinical outcome of ulcerative colitis in children. J Pediatr. 1996;129:81–88.
   PubMed Web of Science ®Google Scholar
• IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). Inflammatory bowel disease in children and adolescents: recommendations for diagnosis—the Porto criteria. J Ped Gastroenterol Nutr. 2005;41:1–7.
   PubMed Web of Science ®Google Scholar
• Uhlig HH, Schwerd T. From genes to mechanisms: the expanding spectrum of monogenic disorders associated with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22:202–212.
   PubMed Web of Science ®Google Scholar
• Choi M, Scholl UI, Ji W, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A. 2009;106:19096–19101.
   PubMed Web of Science ®Google Scholar
• Worthey EA, Mayer AN, Syverson GD, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med. 2011;13:255–262.
   PubMed Web of Science ®Google Scholar
• Moore KWR, de Waal Malefyt R, Coffman L, et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683–765.
   PubMed Web of Science ®Google Scholar
• Bogdan, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med. 1991;174:1549–1555.
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R, Haanen J, Spits H, et al. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression. J Exp Med. 1991;174:915–924.
   PubMed Web of Science ®Google Scholar
• Williams LM, Ricchetti G, Sarma U, et al. Interleukin-10 suppression of myeloid cell activation–a continuing puzzle. Immunology. 2004;113:281–292.
   PubMed Web of Science ®Google Scholar
• Pestka S, Krause CD, Sarkar D, et al. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol. 2004;22:929–979.
   PubMed Web of Science ®Google Scholar
• Jones LB, McGrogan P, Flood TJ, et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol. 2008;152(2):211–218.
   PubMed Web of Science ®Google Scholar
• Marks DJ, Miyagi K, Rahman FZ, et al. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn’s disease. Am J Gastroenterol. 2009;104(1):117–124.
   PubMed Web of Science ®Google Scholar
• Segal BH, Leto TL, Gallin JI, et al. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000;79:170–200.
   PubMed Web of Science ®Google Scholar
• Segal BH, Romani L, Puccetti P. Chronic granulomatous disease. Cell Mol Life Sci. 2009;66:553–558.
   PubMed Web of Science ®Google Scholar
• Holland SM. Chronic granulomatous disease. Clin Rev Allergy Immunol. 2010;38(1):3–10.
   PubMed Web of Science ®Google Scholar
• Marciano BE, Rosenzweig SD, Kleiner DE, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114:462–468.
   PubMed Web of Science ®Google Scholar
• Sumegi J, Huang D, Lanyi A, et al. Correlation of mutations of the SH2D1A gene and Epstein–Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood. 2000;96:3118–3125.
   PubMed Web of Science ®Google Scholar
• Seemayer TA, Gross TG, Egeler RM, et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res. 1995;38:471–478.
   PubMed Web of Science ®Google Scholar
• Sayos J, Wu C, Morra M, et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 1998;395:462–469.
   PubMed Web of Science ®Google Scholar
• Coffey AJ, Brooksbank RA, Brandau O, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet. 1998;20:129–135.
   PubMed Web of Science ®Google Scholar
• Nichols KE, Harkin DP, Levitz S, et al. Inactivating mutations in an SH2 domain encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci U S A. 1998;95:13765–13770.
   PubMed Web of Science ®Google Scholar
• Gilmour KC, Cranston T, Jones A, et al. Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression. Eur J Immunol. 2000;30:1691–1697.
   PubMed Web of Science ®Google Scholar
• Rigaud S, Fondanèche MC, Lambert N, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006;444:110–114.
   PubMed Web of Science ®Google Scholar
• Galbán S, Duckett CS. XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ. 2010;17:54–60.
   PubMed Web of Science ®Google Scholar
• Marsh RA, Madden L, Kitchen BJ, et al. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood. 2010;116:1079–1082.
   PubMed Web of Science ®Google Scholar
• Schmid JP, Canioni D, Moshous D, et al. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP-deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood. 2011;117:1522–1529.
   PubMed Web of Science ®Google Scholar
• Zhao M, Kanegane H, Ouchi K, et al. A novel XIAP mutation in a Japanese boy with recurrent pancytopenia and splenomegaly. Haematologica. 2010;95:688–689.
   PubMed Web of Science ®Google Scholar
• Filipovich AH, Zhang K, Snow AL, et al. X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood. 2010;116:3398–3408.
   PubMed Web of Science ®Google Scholar
• Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol. 2003;15:430–435.
   PubMed Web of Science ®Google Scholar
• Chatila TA, Blaeser F, Ho N, et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest. 2000;106:R75–81.
   PubMed Web of Science ®Google Scholar
• Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27:20–21.
   PubMed Web of Science ®Google Scholar
• Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a model of immune dysregulation. Curr Opin Allergy Clin Immunol. 2002;2:481–487.
   PubMed Web of Science ®Google Scholar
• Gambineri E, Perroni L, Passerini L, et al. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol. 2008;122:1105.e1–1112.e1.
   PubMedGoogle Scholar
• Roncarolo MG, Bacchetta R, Bordignon C, et al. Type 1 T regulatory cells. Immunol Rev. 2001;182:68–79.
   PubMed Web of Science ®Google Scholar
• Groux H, O’Garra A, Bigler M, et al. A CD41 T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389:737–742.
   PubMed Web of Science ®Google Scholar
• Bennett CL, Brunkow ME, Ramsdell F, et al. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA–>AAUGAA) leads to the IPEX syndrome. Immunogenetics. 2001;53:435–439.
   PubMed Web of Science ®Google Scholar
• Heyman MB, Kirschner BS, Gold BD, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr. 2005;146:35–40.
   PubMed Web of Science ®Google Scholar
• Heyman MB. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:63–68.
   PubMed Web of Science ®Google Scholar
• White JM, O’Connor S, Winter HS, et al. Inflammatory bowel disease in African American children compared with other racial/ethnic groups in a multicenter registry. Clin Gastroenterol Hepatol. 2008;6(12):1361–1369. doi:10.1016/j.cgh.2008.07.032. Epub 2008 Oct 9.
   PubMed Web of Science ®Google Scholar
• Gupta N, Bostrom AG, Kirschner BS, et al. Presentation and disease course in early- compared to later- onset pediatric Crohn’s disease. Am J Gastroenterol. 2008;103:2092–2098.
   PubMed Web of Science ®Google Scholar
• Heaton PC, Tundia NL, Schmidt N, et al. National burden of pediatric hospitalizations for inflammatory bowel disease: results from the 2006 kids’ inpatient. J Pediatr Gastroenterol Nutr. 2012;54:477–485.
   PubMed Web of Science ®Google Scholar
• Martín-de-Carpi J, Rodríguez A, Ramosc E, et al. The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25 years (1985–2009): the EXPERIENCE registry. J Crohn’s Colitis. 2014;8:763–769.
   Google Scholar
• De Greef E, Mahachie John JM,, Hoffman I, et al. Profile of pediatric Crohn’s disease in Belgium. J Crohn’s Colitis. 2013;7:e588–e598.
   Google Scholar
• Aloi M, Lionetti P, Barabino A, et al. Phenotype and disease course of early-onset pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:597–605.
   PubMed Web of Science ®Google Scholar
• Benchimol EI, David R, Mack DR, et al. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease. Gastroenterology. 2014;147:803–813.
   PubMed Web of Science ®Google Scholar
• Oliva-Hemker M, Susan Hutfless S, Al Kazzi ES, et al. Clinical presentation and five-year therapeutic management of very early-onset inflammatory bowel disease in a large North American cohort. J Pediatr. 2015;167:527.e3–532.e3.
   PubMed Web of Science ®Google Scholar
• Galatola M, Miele E, Strisciuglio C, et al. Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis. World J Gastroenterol. 2013;19:8659–8670.
   PubMed Web of Science ®Google Scholar
• Shouval DS, Ebens CL, Murchie R, et al. Large B-cell lymphoma in an adolescent patient with IL-10 receptor deficiency and history of infantile inflammatory bowel disease. J Pediatr Gastroenterol Nutr. Ahead of print. doi:10.1097/MPG.0000000000000532.
   Web of Science ®Google Scholar
• Shim JO, Seo JK. Very early-onset inflammatory bowel disease (IBD) in infancy is a different disease entity from adult-onset IBD; one form of interleukin-10 receptor mutations. J Hum Genet. 2014;59:337–341.
   PubMed Web of Science ®Google Scholar
• Shim JO, Hwang S, Yang HR, et al. Interleukin-10 receptor mutations in children with neonatal-onset Crohn’s disease and intractable ulcerating enterocolitis. Eur J Gastroenterol Hepatol. 2013;25:1235–1240.
   PubMed Web of Science ®Google Scholar
• Beser OF, Dominguez Conde C, Serwas NK, et al. Clinical features of interleukin 10 receptor gene mutations in children with very early–onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2015;60:332–338.
   PubMed Web of Science ®Google Scholar
• Pigneur B, Johanna Escher J, Elawad M, et al. Phenotypic characterization of very early-onset IBD due to mutations in the IL10, IL10 receptor alpha or beta gene: a survey of the GENIUS working group. Inflamm Bowel Dis. 2013;19:2820–2828.
   PubMed Web of Science ®Google Scholar
• Neven B, Mamessier E, Bruneau J, et al. A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency. Blood. 2013;122:3713–3722.
   PubMed Web of Science ®Google Scholar
• Lu D, Xu Y, Chen Y, et al. [Interleukin-10 receptor mutations in children with neonatal onset inflammatory bowel disease: genetic diagnosis and pathogenesis]. Zhonghua Er Ke Za Zhi. 2015;53:348–354. Chinese.
   PubMedGoogle Scholar
• Lee CH, Hsu P, Nanan B, et al. Novel de novo mutations of the interleukin-10 receptor gene lead to infantile onset inflammatory bowel disease. J Crohns Colitis. 2014;8:1551–1556.
   PubMed Web of Science ®Google Scholar
• Kotlarz D, Beier R, Murugan D, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology. 2012;143:347–355.
   PubMed Web of Science ®Google Scholar
• Glocker E-O, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. New Engl J Med. 2009;361:2033–2045.
   PubMed Web of Science ®Google Scholar
• Dinwiddie DL, Bracken JM, Bass JA, et al. Molecular diagnosis of infantile onset inflammatory bowel disease by exome sequencing. Genomics. 2013;102:442–447.
   PubMed Web of Science ®Google Scholar
• Mao H, Yang W, Lee PP, et al. Exome sequencing identifies novel compound heterozygous mutations of IL-10 receptor 1 in neonatal-onset Crohn’s disease. Genes Immun. 2012;13:437–442.
   PubMed Web of Science ®Google Scholar
• Soler-Palacína P, Margaretoa C, Llobeta P, et al. Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol Immunopathol. 2007;35:83–89.
   PubMed Web of Science ®Google Scholar
• Raptaki M, Varela I, Spanou K, et al. Chronic granulomatous disease: A 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece. Clin Immunol. 2013;33:1302–1309.
   Web of Science ®Google Scholar
• Helgason KO, Med et Chirc C. A granulomatous chronic disease. Am J Med. 2014;127:e5–e6. doi:10.1016/j.amjmed.2013.12.012.
   Google Scholar
• Isaacs D, Wright VM, Shaw DG, et al. Chronic granulomatous disease mimicking Crohn’s disease. J Pediatr Gastroenterol Nutr. 1985;4:498–501.
   PubMed Web of Science ®Google Scholar
• Imanzade F, Sayarri A, Tajik P. Ulcerative colitis associated with chronic granulomatous disease: case report. Gastroenterol Hepatol Bed Bench. 2015;8:233–235.
   PubMedGoogle Scholar
• Barbato M, Ragusa G, Civitelli F, et al. Chronic granulomatous disease mimicking early-onset Crohn’s disease with cutaneous manifestations. BMC Pediatr. 2014;14:156–159.
   PubMed Web of Science ®Google Scholar
• Sunseri WM, Kugathasan S, Keljo DJ, et al. IBD LIVE case series-case 3: very early-onset inflammatory bowel disease: when genetic testing proves beneficial. Inflamm Bowel Dis. 2015;21:2958–2968.
   PubMed Web of Science ®Google Scholar
• Speckmann C, Lehmberg K, Albert MH, et al. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clin Immunol. 2013;149:133–141.
   PubMed Web of Science ®Google Scholar
• Kelsen JR, Dawany N, Martinez A, et al. A de novo whole gene deletion of XIAP detected by exome sequencing analysis in very early onset inflammatory bowel disease: a case report. BMC Gastroenterol. 2015;15:160–164.
   PubMed Web of Science ®Google Scholar
• Girardelli M, Arrigo S, Barabino A, et al. The diagnostic challenge of very early-onset enterocolitis in an infant with XIAP deficiency. BMC Pediatr. 2015;15:208–214.
   PubMed Web of Science ®Google Scholar
• Dziadzio M, Ammann S, Canning C, et al. Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency. J Clin Immunol. 2015;35:439–444.
   PubMed Web of Science ®Google Scholar
• Beşer OF, Domínguez Conde C, Kutlu T, et al. Inflammatory bowel disease with lethal disease course caused by a nonsense mutation in BIRC4 encoding X-linked inhibitor of apoptosis protein (XIAP). J Pediatr Gastroenterol Nutr. Ahead of print. doi:10.1097/MPG.0000000000000504.
   Google Scholar
• Aguilar C, Christelle Lenoir C, Lambert N, et al. Characterization of Crohn disease in X-linked inhibitor of apoptosis–deficient male patients and female symptomatic carriers. J Allergy Clin Immunol. 2014;134:1131–1141.
   PubMed Web of Science ®Google Scholar
• Zeissig Y, Petersen B-S, Milutinovic S, et al. XIAP variants in male Crohn’s disease. Gut. 2015;64:66–76.
   PubMed Web of Science ®Google Scholar
• Okou DT, Mondal K, Faubion WA, et al. Exome sequencing identifies a novel FOXP3 mutation in a 2-generation family with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014;58:561–568.
   PubMed Web of Science ®Google Scholar
• Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet. 2002;39:537–545.
   PubMed Web of Science ®Google Scholar
• Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn’s disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439–447.
   PubMed Web of Science ®Google Scholar
• Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133:423–432.
   PubMed Web of Science ®Google Scholar
• Li Q, Lee CH, Lauren A, et al. Variants in TRIM22 that affect NOD2 signaling are associated with very-early-onset Inflammatory Bowel Disease. Gastroenterology. 2016;150(5):1196–1207. doi:10.1053/j.gastro.2016.01.031. Epub 2016 Feb 4.
   PubMed Web of Science ®Google Scholar